Company information:
Amdipharm Mercury Uk Limited (No: 08169596)
Address: CAPITAL HOUSE, 85 KING WILLIAM STREET, LONDON, EC4N 7BL
Status: Dissolved
Incorporated: 08-Jun-2012
Accounts Next Due: 30-Sep-2022
Next Confirmation Statement Due: 08-May-2022
Industry Class: 74909 - Other professional, scientific and technical activities n.e.c.
Current Director: VIKRAM LAXMAN KAMATH ( DOB: Sep-1977 From: Dec-2016 )
Current Secretary: ROBERT SULLY ( From: Oct-2018 )
Resigned Director: ADEEL AHMAD ( DOB: Oct-1973 From: Jan-2016 To: Jan-2022 )
Resigned Director: JOHN BEIGHTON ( DOB: Jan-1959 From: Sep-2013 To: Dec-2016 )
Resigned Director: GRAEME NEVILLE DUNCAN ( DOB: Dec-1973 From: Nov-2018 To: Jan-2022 )
Resigned Director: GRAEME NEVILLE DUNCAN ( DOB: Dec-1973 From: Nov-2018 To: Jan-2022 )
Resigned Director: ALEXANDER FRANCIS STEWART LESLIE ( DOB: Dec-1979 From: Aug-2012 To: Sep-2013 )
Resigned Director: STUART ANDERSON MCALPINE ( DOB: Oct-1966 From: Aug-2012 To: Sep-2013 )
Resigned Director: SUPRAJ RAM RAJAGOPALAN ( DOB: May-1978 From: Aug-2012 To: Sep-2013 )
Resigned Director: ANTONIE PIETER VAN TIGGELEN ( DOB: Jul-1970 From: Sep-2013 To: Jan-2016 )
Resigned Secretary: ROBERT SULLY ( From: Nov-2013 To: Dec-2016 )
Resigned Secretary: KEVIN WHALE ( From: Aug-2012 To: Nov-2013 )
Resigned Secretary: DAVID RICHARD WILLIAMS ( From: Dec-2016 To: Oct-2018 )
Persons of Significant Control:
Amdipharm Mercury Holdco Uk Limited, 85 King William Street, London, EC4N 7BL, England: Ownership of shares – 75% or more, Ownership of voting rights - 75% or more, Right to appoint and remove directors (Notified: 2018-08-10, Ceased: 2020-03-27)
The Blackstone Group Inc., 345 Park Avenue, New York, 10154, United States: Ownership of shares – More than 25% but not more than 50%, Ownership of voting rights - More than 25% but not more than 50% (Notified: 2020-03-27, Ceased: 2021-06-01)
Amdipharm Mercury Holdco Uk Limited, Capital House King William Street, London, EC4N 7BL, England: Ownership of shares – 75% or more, Ownership of voting rights - 75% or more, Right to appoint and remove directors (Notified: 2021-06-01)